
iGan Partners
Description
iGan Partners is a prominent Canadian venture capital firm based in Toronto, specializing in early-stage investments within the digital health, MedTech, and enterprise software sectors. The firm distinguishes itself through its hands-on approach, aiming to provide not just capital but also strategic guidance and operational support to its portfolio companies. Their investment thesis centers on identifying disruptive technologies and innovative solutions that address critical needs in their target industries, primarily focusing on companies with strong intellectual property and scalable business models.
iGan Partners typically invests in companies at the Seed to Series A stages, demonstrating a commitment to nurturing startups from their foundational phases. Their initial investments generally range from $2 million to $5 million, providing substantial early capital to fuel growth and product development. Beyond the initial cheque, iGan Partners is prepared to offer significant follow-on capital, with the capacity to invest up to $15 million throughout a company's lifecycle, supporting subsequent funding rounds and expansion initiatives. This flexible funding strategy allows them to maintain a long-term partnership with their portfolio companies.
With a robust portfolio, iGan Partners has established itself as a significant player in the Canadian tech ecosystem. As of early 2024, their Crunchbase profile indicates a total of 33 investments, showcasing their active participation in the market. The firm has also demonstrated a track record of successful exits, with 5 reported exits, validating their investment selection and value creation strategies. Their most recent fund, iGan Partners Fund III, aims to continue their focus on high-growth opportunities in their specialized verticals, reinforcing their position as a leading early-stage investor in Canada's burgeoning technology landscape.
Investor Profile
iGan Partners has backed more than 25 startups, with 5 new investments in the last 12 months alone. The firm has led 10 rounds, about 40% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in Canada, United States.
- Strong thematic focus on Health Care, Medical Device, Medical.
- Led 4 rounds in the past year.
- Typical check size: $2M – $5M.
Stage Focus
- Seed (32%)
- Series A (24%)
- Series Unknown (20%)
- Series C (12%)
- Pre Seed (4%)
- Series B (4%)
- Convertible Note (4%)
Country Focus
- Canada (84%)
- United States (16%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Artificial Intelligence (Ai)
- Software
- Machine Learning
- Information Technology
- Wellness
- Mhealth
- Analytics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.